Sofosbuvir and ledipasvir improve patient-reported outcomes in patients co-infected with hepatitis C and human immunodeficiency virus. - Younossi, Z. M.; Stepanova, M.; Sulkowski, M.; Naggie, S.; Henry, L.; Hunt, S. (Journal of Viral Hepatitis, 2016)